Profile
John C.
McKew is currently Associate Professor at Boston University School of Medicine and President & Chief Scientific Officer at Lumos Pharma, Inc. Former positions include Chairman at American Chemical Society, Director at Wyeth Research, Scientific Director at National Center for Advancing Translational Sciences (2013-2014), Chief Scientific Officer at NewLink Genetics Corp.
(2020), Vice President-Research at aTyr Pharma, Inc. (2014-2016), Principal at National Institutes of Health (2010-2014), and Chief Scientific Officer at Lumos Pharma Sub, Inc. (2016-2020).
Education includes undergraduate studies at Stony Brook University and a doctorate from the University of California, Davis.
John McKew active positions
| Companies | Position | Start |
|---|---|---|
| LUMOS PHARMA, INC. | President | 01/08/2021 |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of John McKew
| Companies | Position | End |
|---|---|---|
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Chief Tech/Sci/R&D Officer | 31/03/2020 |
| ATYR PHARMA, INC. | Chief Tech/Sci/R&D Officer | 01/01/2016 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Corporate Officer/Principal | 01/01/2014 |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National agency | Chief Tech/Sci/R&D Officer | 01/01/2014 |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Director/Board Member | - |
Training of John McKew
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
NewLink Genetics Corp.
NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Stony Brook University
Stony Brook University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Wyeth Research
Wyeth Research Miscellaneous Commercial ServicesCommercial Services Discovers and develops platforms encompassing pharmaceuticals | Commercial Services |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Health Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences National AgencyGovernment National agency | Government |
Lumos Pharma, Inc.
Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases | Health Technology |
- Stock Market
- Insiders
- John McKew
















